Invention Grant
- Patent Title: Oral controlled release pharmaceutical compositions of bepotastine
- Patent Title (中): 贝司他宁的口服控释药物组合物
-
Application No.: US13982561Application Date: 2012-02-03
-
Publication No.: US09421165B2Publication Date: 2016-08-23
- Inventor: Ashish Ashokrao Deshmukh , Pravin Meghrajji Bhutada , Sajeev Chandran , Shirishkumar Kulkarni
- Applicant: Ashish Ashokrao Deshmukh , Pravin Meghrajji Bhutada , Sajeev Chandran , Shirishkumar Kulkarni
- Applicant Address: IN Mumbai, Maharashtra
- Assignee: LUPIN LIMITED
- Current Assignee: LUPIN LIMITED
- Current Assignee Address: IN Mumbai, Maharashtra
- Agency: Merchant & Gould P.C.
- Priority: IN157/KOL/2011 20110203
- International Application: PCT/IB2012/050506 WO 20120203
- International Announcement: WO2012/104818 WO 20120809
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/20 ; A61K9/24 ; A61K9/28 ; A61K31/4545
Abstract:
The present invention relates to oral controlled release pharmaceutical compositions comprising Bepotastine. The oral controlled release pharmaceutical composition comprises Bepotastine or pharmaceutically acceptable salts thereof and at least one release controlling agent. The present invention also provides the use of oral controlled release pharmaceutical compositions of Bepotastine for the treatment of allergic rhinitis and for the treatment of pruritus caused by urticaria.
Public/Granted literature
- US20130317063A1 ORAL CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF BEPOTASTINE Public/Granted day:2013-11-28
Information query
